321 related articles for article (PubMed ID: 20665135)
1. Update on biologic therapy in the management of axial spondyloarthritis.
Heldmann F; Dybowski F; Saracbasi-Zender E; Fendler C; Braun J
Curr Rheumatol Rep; 2010 Oct; 12(5):325-31. PubMed ID: 20665135
[TBL] [Abstract][Full Text] [Related]
2. [Biologics in the early treatment of ankylosing spondylitis and related forms of spondyloarthritis].
Langer HE
Wien Med Wochenschr; 2008; 158(7-8):200-5. PubMed ID: 18500471
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapies for spondyloarthritis: what is new?
Baraliakos X; Braun J
Curr Rheumatol Rep; 2012 Oct; 14(5):422-7. PubMed ID: 22855297
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.
Rudwaleit M; Van den Bosch F; Kron M; Kary S; Kupper H
Arthritis Res Ther; 2010; 12(3):R117. PubMed ID: 20553600
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
9. Treatment of non-radiographic axial spondyloarthritis: it is only the beginning.
van der Horst-Bruinsma IE
Ann Rheum Dis; 2013 Jun; 72(6):789-90. PubMed ID: 23667168
[No Abstract] [Full Text] [Related]
10. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases].
Lapadula G
Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352
[TBL] [Abstract][Full Text] [Related]
11. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
Lanfant-Weybel K; Lequerré T; Vittecoq O
Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
[TBL] [Abstract][Full Text] [Related]
12. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
[TBL] [Abstract][Full Text] [Related]
13. [Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis].
Juanola Roura X; Zarco Montejo P; Sanz Sanz J; Muñoz Fernández S; Mulero Mendoza J; Linares Ferrando LF; Gratacós Masmitja J; García de Vicuña R; Fernandez Carballido C; Collantes Estevez E; Batlle Gualda E; Ariza Ariza R; Loza Santamaría E
Reumatol Clin; 2011; 7(2):113-23. PubMed ID: 21794794
[TBL] [Abstract][Full Text] [Related]
14. Absence of radiographic progression at two years in a cohort of patients with non-radiographic axial spondyloarthritis treated with TNF-α blockers.
Almirall M; López-Velandia JG; Maymó J
Reumatol Clin; 2014; 10(2):134-5. PubMed ID: 23827199
[No Abstract] [Full Text] [Related]
15. Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.
Kalden JR
Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S34-40. PubMed ID: 12110156
[TBL] [Abstract][Full Text] [Related]
16. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and role of the gastrointestinal system in spondyloarthritides.
Jacques P; Van Praet L; Carron P; Van den Bosch F; Elewaut D
Rheum Dis Clin North Am; 2012 Aug; 38(3):569-82. PubMed ID: 23083756
[TBL] [Abstract][Full Text] [Related]
19. Biologic therapy of psoriatic arthritis.
Gladman DD
Reumatismo; 2007; 59 Suppl 1():85-7. PubMed ID: 17828353
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antitumor necrosis factor(α) agents on patients with ankylosing spondylitis.
Ren L; Li J; Luo R; Tang R; Zhu S; Wan L
Am J Med Sci; 2013 Dec; 346(6):455-61. PubMed ID: 23715113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
